About MedLogix
MedLogix is a Healthcare company based in Schaumburg (United States) founded in 2000, and was acquired by CiTRUS in September 2023. Medical communications, consulting services, and healthcare software are provided. Its focus areas include HealthTech, Life Sciences Tech, Medical Event Management and KOL Databases. Its competitors include Viscira and QPharma.
Company details
MedLogix Communications provides medical communications and consulting services and software. Digital solutions include Speakers Bureau Management System - compliant management of speaker training process; Virtual Speaker Training Portal to streamline all processes involved with speakers bureau programs; KOL Virtual Advisory Boards whcih provide a two-way platform for communicating about topics such as new FDA approvals or indications, clinical trial data, and disease education; KOL Management System - system to centralize and manage KOL profiles; Digital Patient for having interactive educational activity involving patient case studies; and ePresentation Creation Systems which allow presenters to create regulatory-compliant promotional slide presentations consisting of regulatory-approved slides. It also allows users to generate and uses KOL and sales rep narrates videos. It also provides consulting, content development and meeting planning services.
- Headquarters Schaumburg, United States
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website medlogix.org
- Social LinkedIn
- Acquired by CiTRUS (Sep 2023)
- InvestorsCitrus Health Group
& 1 more
- Acquired byCiTRUS
(Sep 2023)
Investors in MedLogix
MedLogix has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Citrus Health Group and NaviMed Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
NaviMed Capital is focused on healthcare industry investments. | navimed.com | Rosslyn, United States | ||
Healthcare data mining and analytics are provided by CiTRUS. | 2018 | citrushealthgroup.com | Philadelphia, United States |
Investor details for MedLogix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of MedLogix
2 dated milestones of MedLogix across 23 years, from founding to its latest funding, stage changes and deals.
- Founded MedLogix is founded.
- Exit Acquired by CiTRUS.
Competitors of MedLogix
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| viscira.com | 2007 | San Francisco, United States | 104 | Media marketing solutions are provided for life sciences sectors. | ||
| qpharmacorp.com | 1994 | Morristown, United States | Provides pharmaceutical compliance, distribution, and digital tools for biotech sectors. |
Detailed competitors of MedLogix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as MedLogix (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Medlogix
Complete news archive for MedLogix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MedLogix
MedLogix was founded in 2000.
MedLogix is headquartered in Schaumburg, United States. It is registered at Schaumburg, Illinois, United States.
MedLogix Communications provides medical communications and consulting services and software. Digital solutions include Speakers Bureau Management System - compliant management of speaker training process; Virtual Speaker Training Portal to streamline all processes involved with speakers bureau programs; KOL Virtual Advisory Boards whcih provide a two-way platform for communicating about topics such as new FDA approvals or indications, clinical trial data, and disease education; KOL Management System - system to centralize and manage KOL profiles; Digital Patient for having interactive educational activity involving patient case studies; and ePresentation Creation Systems which allow presenters to create regulatory-compliant promotional slide presentations consisting of regulatory-approved slides. It also allows users to generate and uses KOL and sales rep narrates videos. It also provides consulting, content development and meeting planning services.
MedLogix has 2 investors. Key investors include Citrus Health Group, and NaviMed Capital.
Yes. MedLogix was acquired by CiTRUS in September 2023.

